Inventor
SHELLEY FORCE ALDRED
Inventor
US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides40%
A61KPreparations for medical, dental or toiletry purposes27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
A01KAnimal husbandry7%
C12NMicroorganisms or enzymes7%
PatentTitleYear
12,570,717Anti-B-cell maturation antigen chimeric antigen receptors with human domains202612,495,776Transgenic non-human animals producing modified heavy chain-only antibodies202511,970,540Anti-BCMA heavy chain-only antibodies202411,613,572CD3 binding antibodies202311,505,606CD3 binding antibodies202211,427,642Anti-BCMA heavy chain-only antibodies2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to TENEOBIO INC (5)· patent assignee history
2022Patents assigned to TENEOONE INC (1)· patent assignee history
2022–2026Based in US· patent location history
2026Patents assigned to US HEALTH (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| TENEOBIO INC | 5 | 2022–2026 |
| TENEOONE INC | 1 | 2022 |
| US HEALTH | 1 | 2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 6 | 2022–2026 |